User profiles for M. A. Moody
 | M. Anthony MoodyAssociate Professor of Pediatrics, Duke University Verified email at mc.duke.edu Cited by 11679 |
Antibody polyspecificity and neutralization of HIV-1: a hypothesis
BF Haynes, MA Moody, L Verkoczy… - Human …, 2005 - content.iospress.com
… study SLE and APS patients both for the incidence of HIV-1 infection and for the quality of
anti-HIV-1 neutralizing antibodies that these patients make after HIV1 infection (Moody, MA, …
anti-HIV-1 neutralizing antibodies that these patients make after HIV1 infection (Moody, MA, …
[HTML][HTML] A systematic review of syphilis serological treatment outcomes in HIV-infected and HIV-uninfected persons: rethinking the significance of serological non …
…, LG Yang, JC Salazar, MS Cohen, MA Moody… - BMC infectious …, 2015 - Springer
Background Syphilis remains a global public health threat and can lead to severe
complications. In addition to resolution of clinical manifestations, a reduction in nontreponemal …
complications. In addition to resolution of clinical manifestations, a reduction in nontreponemal …
Effect of antipyretic analgesics on immune responses to vaccination
While antipyretic analgesics are widely used to ameliorate vaccine adverse reactions, their
use has been associated with blunted vaccine immune responses. Our objective was to …
use has been associated with blunted vaccine immune responses. Our objective was to …
[PDF][PDF] In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
…, TD Scobey, W Rountree, Y Wang, MA Moody… - Cell, 2021 - cell.com
SARS-CoV-2-neutralizing antibodies (NAbs) protect against COVID-19. A concern regarding
SARS-CoV-2 antibodies is whether they mediate disease enhancement. Here, we isolated …
SARS-CoV-2 antibodies is whether they mediate disease enhancement. Here, we isolated …
Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors
…, MS Seaman, JF Whitesides, MA Moody… - Journal of …, 2011 - Am Soc Microbiol
… Three hundred eighty four-well plates (Corning Life Sciences, Lowell, MA) were coated
overnight at 4C with 15 μl of purified HIV-1 envelope proteins at optimized concentrations of …
overnight at 4C with 15 μl of purified HIV-1 envelope proteins at optimized concentrations of …
Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin
Seasonal antigenic drift of circulating influenza virus leads to a requirement for frequent
changes in vaccine composition, because exposure or vaccination elicits human antibodies with …
changes in vaccine composition, because exposure or vaccination elicits human antibodies with …
Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family
M Bonsignori, J Pollara, MA Moody, MD Alpert… - Journal of …, 2012 - Am Soc Microbiol
The ALVAC-HIV/AIDSVAX-B/E RV144 vaccine trial showed an estimated efficacy of 31%.
RV144 secondary immune correlate analysis demonstrated that the combination of low …
RV144 secondary immune correlate analysis demonstrated that the combination of low …
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
…, J Pollara, M Bonsignori, MA Moody… - Proceedings of the …, 2013 - National Acad Sciences
Analysis of correlates of risk of infection in the RV144 HIV-1 vaccine efficacy trial demonstrated
that plasma IgG against the HIV-1 envelope (Env) variable region 1 and 2 inversely …
that plasma IgG against the HIV-1 envelope (Env) variable region 1 and 2 inversely …
[PDF][PDF] Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2
The RV144 HIV-1 trial of the canary pox vector (ALVAC-HIV) plus the gp120 AIDSVAX B/E
vaccine demonstrated an estimated efficacy of 31%, which correlated directly with antibodies …
vaccine demonstrated an estimated efficacy of 31%, which correlated directly with antibodies …
Influence of HLA-C expression level on HIV control
…, D Heckerman, JL Stein, KA Soderberg, MA Moody… - Science, 2013 - science.org
A variant upstream of human leukocyte antigen C (HLA-C) shows the most significant
genome-wide effect on HIV control in European Americans and is also associated with the level of …
genome-wide effect on HIV control in European Americans and is also associated with the level of …